|
Biogen Inc
neutralizing anti-lc1 moab 1a Neutralizing Anti Lc1 Moab 1a, supplied by Biogen Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/monoclonal+antibody+105/monoclonal+anti+lc+1+antibodies+lipo+105+1+b/pmc01905455-64-40-56 Average 90 stars, based on 1 article reviews
neutralizing anti-lc1 moab 1a - by Bioz Stars,
2026-11
90/100 stars
|
Buy from Supplier |
|
Tracon Inc
humanized endoglin monoclonal antibody tracon 105 ![]() Humanized Endoglin Monoclonal Antibody Tracon 105, supplied by Tracon Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/monoclonal+antibody+105/humanized+endoglin+monoclonal+antibody+tracon+105/pmc09163327-230-23-19 Average 90 stars, based on 1 article reviews
humanized endoglin monoclonal antibody tracon 105 - by Bioz Stars,
2026-11
90/100 stars
|
Buy from Supplier |
|
GeneTex
a2b5 mouse monoclonal antibody [105]_#gtx14538 ![]() A2b5 Mouse Monoclonal Antibody [105] #Gtx14538, supplied by GeneTex, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/monoclonal+antibody+105/a2b5+mouse+monoclonal+antibody++105+++gtx14538/pmc06712005__41398_2019_529_MOESM1_ESM-137-111-115 Average 90 stars, based on 1 article reviews
a2b5 mouse monoclonal antibody [105]_#gtx14538 - by Bioz Stars,
2026-11
90/100 stars
|
Buy from Supplier |
|
Diagnostic BioSystems
anticd-105 monoclonal antibody sn6h ![]() Anticd 105 Monoclonal Antibody Sn6h, supplied by Diagnostic BioSystems, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/monoclonal+antibody+105/anticd+105+monoclonal+antibody+sn6h/pm17334712-29-7-11 Average 90 stars, based on 1 article reviews
anticd-105 monoclonal antibody sn6h - by Bioz Stars,
2026-11
90/100 stars
|
Buy from Supplier |
|
HCV NS5B RdRp 92 105 mouse monoclonal antibody clone 6B12 Aff Purified
|
Buy from Supplier |
|
CD25 Monoclonal Antibody for IF, Flow, ELISA
|
Buy from Supplier |
|
GUSB Monoclonal Antibody for Western Blot, IHC (F), ELISA
|
Buy from Supplier |
|
A2B5 Monoclonal Antibody for Western Blot, IF, ICC, IHC, Flow
|
Buy from Supplier |
Image Search Results
Journal: Communications Biology
Article Title: Hypoxia-induced inhibin promotes tumor growth and vascular permeability in ovarian cancers
doi: 10.1038/s42003-022-03495-6
Figure Lengend Snippet: a Quantitation of endothelial cell permeability by measuring FITC-dextran changes across a HMEC-1 monolayer treated with 1 nM inhibin A in the presence or absence of (i) 100 μg/mL TRC105 or (ii) 10 ng/mL ALK1-Fc. FITC-dextran diffusion across the HMEC-1 monolayer at 4 h is presented. Mean ± SD, n = 4 for i and n = 3 for ii. n.s. not significant; *** p < 0.001; **** p < 0.0001. b Internalization of VE-cadherin measured by cell surface biotinylation. (i) Biotin labeling of cell surface proteins was performed on MEEC WT or MEEC ENG −/−. Internalization was induced by treatment with 1 nm Inhibin A for 30 min at 37 °C followed by stripping of cell surface biotin. Internalized VE-cadherin was detected by IP with neutravidin resin and (ii) immunoblotting with anti-VE-cadherin and (iii) quantitated as internalized VE-cadherin over input VE-cadherin normalized to 37 °C control. Mean ± SD, n = 2. n.s. not significant; * p < 0.05, unpaired t -test. c , d Patch/FRAP studies on the effect of inhibin A on endoglin-ALK1 ( c ) and endoglin-ALK4 ( d ) complex formation. COS7 cells were transfected with myc-ALK1 and HA-endoglin ( c ) or with (each vector HA-ALK4 and myc-endoglin) (D) (each vector alone, or together). c After 24 h, singly transfected cells were labeled for FRAP by anti-tag Fab’ followed by fluorescent secondary Fab’ (Methods) and subjected to FRAP studies. For patch/FRAP, cells were subjected to protocol 1 of IgG-mediated patching/cross-linking (CL) (Methods), resulting in HA-endoglin patched and labeled by Alexa 488-GαR IgG (designated “CL: IgG αHA”), whereas myc-ALK1 is labeled by monovalent Fab’ (with secondary Alexa 546-GαM Fab’). In control experiments without HA-endoglin CL, the IgG labeling of the HA tag was replaced by exclusive Fab’ labeling. Where indicated, inhibin A (4 nM) was added during the fluorescent labeling step and maintained throughout the measurement. Representative FRAP curves are depicted in panels (i–iii), showing the lateral diffusion of singly expressed myc-ALK1 (i), singly expressed HA-endoglin immobilized by IgG CL (ii) and of myc-ALK1 in the presence of co-expressed and IgG-crosslinked HA-endoglin in the presence of inhibin A (iii). Panels (iv–v) depict average R f (iv) and D values (v) of multiple experiments. Bars represent mean ± SEM values, with the number of measurements (each conducted on a different cell) shown in each bar. Some of these numbers are lower in the D values panels, since only R f can be extracted from FRAP curves yielding less than 20% recovery. Asterisks indicate significant differences between the R f values of the pairs indicated by brackets (**** p < 1 × 10 −15 ; *** p = 1 × 10 −9 ; one-way ANOVA followed by Bonferroni post-hoc test). d Cells were labeled for patch/FRAP using protocol 2 (Methods), leading to immobilization (CL) of the myc-endoglin and Fab’ labeling of HA-ALK4, whose lateral diffusion was then measured by FRAP. (i) Average R f values. (ii) Average D values. Bars are mean ± SEM with number of measurements ( n ) depicted in each bar. Asterisks indicate significant differences between the R f values of the pairs indicated by brackets ( * *** p < 1 × 10 −15 ; ** p = 5.6 × 10 −3 ; one-way ANOVA followed by Bonferroni post-hoc test). No significant differences were found between D values following myc-endoglin immobilization.
Article Snippet: To evaluate if ALK1 and endoglin are required for inhibin’s influence on vascular permeability, we treated HMEC-1 cells with
Techniques: Quantitation Assay, Permeability, Diffusion-based Assay, Labeling, Stripping Membranes, Western Blot, Control, Transfection, Plasmid Preparation